Harrow Health, Inc. ( HROW) - Stock Earnings
HROW Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 10, 2026, midnight | — / — | — | — / — | — |
HROW Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 1.0 million USD | 71.6 million USD |
| 2025Q4 | 6.6 million USD | 89.1 million USD |
| 2026Q1 | -27.6 million USD | 44.2 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
HROW Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -24.4 million USD | 130.2 million USD |
| 2024 | -17.5 million USD | 199.6 million USD |
| 2025 | -5.1 million USD | 272.3 million USD |
| 2026 Est. | — | — |
HROW
Price: $42.83
Earnings Per Share: -0.38 USD
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 114053
Market Capitalization: 1.6 billion